En español
NIDA

Instructions to Principal Investigators Applying for Research Supplements to Promote Diversity in Health-Related Research (Diversity Supplements) at the National Institute on Drug Abuse (NIDA)

The Research Supplements to Promote Diversity in Health-Related Research (or "Diversity Supplements") program was established by the National Institutes of Health (NIH) to increase the numbers of underrepresented scientists participating in biomedical and behavioral research.  Funding is provided to current NIH research grants to support certain ethnic minority, disabled, or disadvantaged students or investigators interested in pursuing careers in biomedical or behavioral research sciences, through research experiences with NIH-funded investigators.

NIDA strongly supports and encourages participation in its diversity supplements program.  Support is available to underrepresented ethnic minority and disabled students and investigators at the undergraduate, pre-doctoral, postdoctoral, and investigator levels.  For a description of the NIH diversity supplements program, refer to NIH Program Announcement  PA-16-288 "Research Supplements to Promote Diversity in Health-Related Research."

The diversity supplements program at NIDA is intended to enhance the number of underrepresented scientists in drug abuse research by providing funding to underrepresented ethnic minority, disabled and disadvantaged students and investigators pursuing careers as biomedical or behavioral scientists.  Candidates must not be current recipients of Public Health Service (PHS) funding support at the time of application submission.  In addition, diversity supplement candidates may not be removed from an NIH funding source for placement on a diversity supplement.

Principal Investigators interested in applying for NIDA diversity supplements are urged to contact Pamela Goodlow, NIDA Office of Diversity and Health Disparities, prior to submitting an application:  301-435-0925, or e-mail: pg46n@nih.gov

It is important that applicants follow all instructions in the Application Guide (PHS 398 Application Guide or SF 424 Application Guide, as appropriate) except where instructed to do otherwise in this document, the PA-16-288, or in a Notice from the NIH Guide for Grants and Contracts.  Electronic submission is highly encouraged.

IMPORTANT:  In order to avoid delays in review and funding, NIDA recommends Principal Investigators use the following format in preparing applications:

  1. Complete all information on the front (face) page of the appropriate application form (provided in the SF 424 or the PHS 398 application packet).  Include the title and grant number of the parent grant, and specify "Diversity Supplement" or "Research Supplements to Promote Diversity in Health-Related Research."  Signature of the Applicant Organization official with authority to sign grant applications is required.  If using electronic submission with the SF424 application package, follow package directions for providing administrative information.
  2. Page numbers should be inserted, when applicable.
  3. An abstract or summary of the funded parent grant or project must be included.  The abstract page from the funded parent project is preferred.
  4. Provide detailed description (at least 2-4 pages) of the research experience proposed for the candidate.  In this section, include:  1)  description of actual research proposed for the candidate; 2) detail of how the proposed research experience will increase/enhance the candidate’s research capabilities; and, 3) a connection of the of the proposed research experience to the overall goals of the parent grant.  Proposed research must fall within the scientific scope of the parent grant.  Diversity Supplements may not be used to support new research.

    It is expected that candidates at the postdoctoral or investigator level provide evidence that research proposed during the funding period will enhance overall research skills and lead directly to careers as independent drug abuse investigators.  Research plan should address specific skills, responsibilities, and activities that demonstrate the candidate’s increasing independence as a researcher, and any need for additional training that will result in an independent substance abuse research career.  Include timeline for applying for independent research funding.  Funding for candidates at the postdoctoral or investigator level is limited to two years.
  5. A detailed plan for mentoring the candidate must be included.  Describe mentoring activities (e.g., routine meetings, supervision in writing, publishing; etc.) and support throughout the period of funding, specifying the mentor(s) for each major research activity. Should one or more mentors be identified to work closely with the candidate, identify each mentor by name and area(s) of expertise, and provide a brief description of research training or experiences to be obtained from each.
  6. A plan for transition to independence for the candidate, must be included.  Plan should incorporate activities that will result in candidate’s successful transition to an independently-funded research training or early research career, such as writing and submitting grant application(s), submitting manuscripts for publication, etc.  Include plans for funding after diversity supplement ends; be as specific as possible in identifying funding mechanisms (K99/R00, R03, F31, F32, etc.). Contingency plans for continued support must be included.
  7. A written timetable for the proposed research experience, outlining the candidate’s major research and development activities by month and year, must be provided.  In this section, include all proposed research and other activities (examples: publications, presentations, didactic training, if necessary, grant applications, etc.) that will augment the candidate’s research and career development during the supplement period.
  8. A signed personal statement (1-2 pages) from the proposed candidate, outlining his/her interest in pursuing a long-term career in the research sciences, particularly in some aspect of drug abuse/addiction, must be included.  A current biographical sketch or curriculum vitae (use “bio sketch” page from SF 424 or the PHS 398 application packet) from the candidate that details education, work experience, science and research experiences, and publications, must be included as well.
  9. Complete contact information for the candidate must be included and should contain permanent e-mail address and telephone number(s). 
  10. A copy of the most recent transcript, if the candidate is a student at the undergraduate or graduate level, must be provided. Transcripts are not required for postdoctoral or investigator-level candidates.
  11. Proposed budget, using the budget pages from SF 424 or PHS 398 grant application package for proposed initial budget period and future years.  All columns and subheadings ("percentage effort on project," "fringe benefits," etc.) must be complete; provide detailed justification for line items such as "supplies" and "other expenses." 
    • Undergraduate: up to $12.00/hr.*
    • Pre-doctoral: up to $28,000/yr. total, for salary, fringe benefits, and/or tuition remission.
    • * Postdoctoral: up to $50,000/yr.
    • * Investigator: up to $60,000/yr.* (note: at least 50% effort on the parent project is required of candidates at the investigator level) 

      *For all levels of support, up to $1,000/year may be requested for “general supplies,” and up to $1,500/year may be requested for conference/meetings travel.  Salary requested must approximate the percentage effort dedicated on the parent project, commensurate with the institution’s base salary.
  12. Enclose a signed statement from the Principal Investigator of the parent grant which verifies the eligibility of the candidate to receive funding through the diversity supplements program based on underrepresented racial ethnicity, disability, or disadvantaged status.  Be specific regarding the category of eligibility and provide further information as needed, such as the exact ethnicity or nature of disability of the candidate).  Indicate U.S. citizenship or permanent residency, and provide information on any current and/or prior PHS research support received (note: candidates receiving current PHS funding are not eligible to receive NIH diversity supplement support).
  13. If applicable, documentation that proposed research experience has received approval by Institutional Animal Care and Use Committee (IACUC) or human subjects Institutional Review Board (IRB) should be included.
  14. If candidate is a student or faculty at an institution different from that of the parent grant institution a letter from an official at the candidate’s institution indicating support and approval of participation by the candidate with no distraction or interference from his/her studies or professional responsibilities must be included in the application.
  15. Send, via one of the following options:
    • Submit SF 424 application electronically via Grants.gov (if submitting electronically, contact Ms. Goodlow of plans to apply electronically prior to actual submission) 
    • E-mail PHS 398 application directly to Pamela Goodlow, with application attached in PDF document format;
    • Mail, via Federal Express or overnight mail service, original signed application and two (3) copies;

      Mailed applications should be sent via Federal Express or overnight mail to:

      Pamela Goodlow
      Office of Diversity and Health Disparities
      National Institute on Drug Abuse
      6001 Executive Boulevard
      Room 3105

      Rockville, MD 20852

This page was last updated August 2016